Zhang Yibo, Zhong Xuanlei, Xi Zhichao, Li Yang, Xu Hongxi
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai, China.
J Ginseng Res. 2023 Mar;47(2):183-192. doi: 10.1016/j.jgr.2022.11.003. Epub 2022 Nov 17.
Viral infections are known as one of the major factors causing death. Ginseng is a medicinal plant that demonstrated a wide range of antiviral potential, and saponins are the major bioactive ingredients in the genus with vast therapeutic potential. Studies focusing on the antiviral activity of the genus plant-derived agents (extracts and saponins) and their mechanisms were identified and summarized, including contributions mainly from January 2016 until January 2022. , , and were included in the review as valuable medicinal herbs against infections with 14 types of viruses. Reports from 9 extracts and 12 bioactive saponins were included, with 6 types of protopanaxadiol (PPD) ginsenosides and 6 types of protopanaxatriol (PPT) ginsenosides. The mechanisms mainly involved the inhibition of viral attachment and replication, the modulation of immune response by regulating signaling pathways, including the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway, cystathionine γ-lyase (CSE)/hydrogen sulfide (HS) pathway, phosphoinositide-dependent kinase-1 (PDK1)/ protein kinase B (Akt) signaling pathway, c-Jun N-terminal kinase (JNK)/activator protein-1 (AP-1) pathway, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway. This review includes detailed information about the mentioned antiviral effects of the genus extracts and saponins and , and in human clinical trials, which provides a scientific basis for ginseng as an adjunctive therapeutic drug or nutraceutical.
病毒感染是导致死亡的主要因素之一。人参是一种具有广泛抗病毒潜力的药用植物,皂苷是该属植物中的主要生物活性成分,具有巨大的治疗潜力。对该属植物衍生制剂(提取物和皂苷)的抗病毒活性及其作用机制的研究进行了识别和总结,时间主要涵盖2016年1月至2022年1月。人参、西洋参和三七被纳入综述,作为对抗14种病毒感染的珍贵草药。纳入了9种提取物和12种生物活性皂苷的报告,其中包括6种原人参二醇(PPD)型人参皂苷和6种原人参三醇(PPT)型人参皂苷。其作用机制主要包括抑制病毒附着和复制,通过调节信号通路来调节免疫反应,这些信号通路包括Janus激酶(JAK)/信号转导子和转录激活子(STAT)通路、胱硫醚γ-裂解酶(CSE)/硫化氢(HS)通路、磷酸肌醇依赖性激酶-1(PDK1)/蛋白激酶B(Akt)信号通路、c-Jun氨基末端激酶(JNK)/激活蛋白-1(AP-1)通路以及活化B细胞核因子κB(NF-κB)通路。本综述包含了该属提取物和皂苷在体外及人体临床试验中上述抗病毒作用的详细信息,这为将人参作为辅助治疗药物或营养保健品提供了科学依据。